(Q34626994)
Statements
New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment (English)
Alain Sarasin
Brigitte Bressac-de Paillerets
Christine Lasset
Caroline Kannengiesser
Marie-Thérèse Leccia
Marie Françoise Avril
Valerie Bonadona
Agnès Chompret
Dominique Leroux
Luc Thomas
Gilbert Lenoir
1 reference